NRAS exon 2 mutation	Colorectal Cancer	NRAS exon 2 mutation	Colorectal Cancer	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1	panitumumab Resistant: A1 - Approval panitumumab Resistant : A1
NRAS exon 2 mutation	Colorectal Cancer	NRAS exon 2 mutation	Colorectal Cancer	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2	cetuximab Resistant: A2 - Guideline cetuximab Resistant : A2
NRAS exon 2 mutation	Colorectal Cancer	NRAS exon 2 mutation	Colorectal Cancer	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3	bevacizumab Sensitive: C3 – Early Trials bevacizumab Sensitive : C3

NRAS exon 2 mutation

Associations